+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Eldecalcitol increases bone mass in patients with Turner syndrome who have insufficient bone mass acquisition after estrogen replacement therapy



Eldecalcitol increases bone mass in patients with Turner syndrome who have insufficient bone mass acquisition after estrogen replacement therapy



Endocrine Journal 65(6): 629-638



Most patients with Turner syndrome (TS) exhibit amenorrhea due to premature ovarian failure. Therefore, estrogen replacement therapy (ERT) is required; however, even after undergoing ERT, it is not rare for bone mass acquisition to be insufficient. This study was conducted in two stages, involving a cross-sectional and a prospective interventional study. We recruited 52 TS patients undergoing ERT due to amenorrhea (categorized into low (LB group; n = 23), and normal (NB group; n = 29) bone mass groups) and 7 TS patients who maintained ovarian function (spontaneous menstrual cycle group (MC group)) as controls. We compared bone associated markers between the three groups (LB, NB, and MC). Furthermore, the LB group had concomitant treatment with eldecalcitol (ELD) and ERT for 12 months. The bone mineral density (BMD) of the lumber spine (L2-4) and the bone metabolism markers were then compared before and after the treatment. The bone metabolism markers were significantly higher in the LB group than the NB and MC groups. Furthermore, with the concomitant use of ELD and ERT in the LB group, BMD increased significantly (pre-treatment 0.710 ± 0.056 g/cm2 vs. 0.736 ± 0.062 g/cm2 after 12 months; p < 0.001). TS patients with insufficient bone mass acquisition even after ERT were characterized by a higher turnover in bone metabolism. Therefore, the concomitant use of ELD was considered an effective adjuvant therapy for increasing bone mass.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 060887007

Download citation: RISBibTeXText

PMID: 29607913

DOI: 10.1507/endocrj.ej17-0498


Related references

Efficacy of estrogen replacement therapy (ERT) on uterine growth and acquisition of bone mass in patients with Turner syndrome. Endocrine Journal 62(11): 965-970, 2015

Decreased bone mass despite long-term estrogen replacement therapy in young women with Turner's syndrome and previously normal bone density. Fertility & Sterility 72(5): 896-899, 1999

Bone demineralization, biochemical indices of bone remodeling, and estrogen replacement therapy in adults with Turner's syndrome. Journal of Bone and Mineral Research 4(2): 193-198, 1989

Spontaneous, but not induced, puberty permits adequate bone mass acquisition in adolescent Turner syndrome patients. Journal of Bone and Mineral Research 15(10): 2005-2010, 2000

Estrogen therapy initiated at an early age increases bone mineral density in Turner syndrome patients. Endocrine Journal 59(2): 153-159, 2012

Eldecalcitol, a vitamin D analog, reduces bone turnover and increases trabecular and cortical bone mass, density, and strength in ovariectomized cynomolgus monkeys. Bone 57(1): 116-122, 2013

Childhood bone mass acquisition and peak bone mass may not be important determinants of bone mass in late adulthood. Pediatrics 119(Suppl. 2): S131-S136, 2007

Decreased bone mass despite long term estrogen replacement in young women with Turners syndrome and previously normal bone mineral densities. Pediatric Research 43(4 Part 2): 79A, 1998

Effect of estrogen replacement therapy on bone mineral content in girls with Turner syndrome. Obstetrics and Gynecology 79(5 ): 747-751, 1992

92164606 Effect of estrogen replacement therapy on bone mineral content in girls with Turner syndrome. Maturitas 15(3): 255-256, 1992

Bone metabolism and bone mass in patients with thyroid cancer on L-T-4 therapy Longitudinal changes in axial and appendicular bone mass. British Journal of Rheumatology 36(Suppl. 1): 65, 1997

Two polymorphisms in the vitamin D receptor gene--association with bone mass and 5-year change in bone mass with or without hormone-replacement therapy in postmenopausal women: the Danish Osteoporosis Prevention Study. Journal of Bone and Mineral Research 17(8): 1535-1544, 2002

Effect of estrogen replacement therapy on bone and cardiovascular outcomes in women with turner syndrome: a systematic review and meta-analysis. Endocrine 55(2): 366-375, 2017

Bone mass, bone turnover and body composition in former hypothyroid patients receiving replacement therapy. European Journal Of Endocrinology. 134(6): 702-709, 1996

The effect of hormone replacement therapy on bone mass in patients with ovarian failure due to bone marrow transplantation. Maturitas 23(3): 307-312, 1996